4 news items
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
GOVX
4 Apr 24
. During his presentation, titled "Vaccine Induction of Broadly-Specific Antibody and T Cell Responses to Combat SARS-CoV-2 Variation
GeoVax To Present Data On GEO-CM04S1, A Next Generation Covid-19 Vaccine, At The World Vaccine Congress
GOVX
28 Mar 24
Induction of Broadly-Specific Antibody and T Cell Responses to Combat SARS-CoV-2 VariationDr. Newman's presentation will focus on results
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
GOVX
29 Feb 24
no serious adverse events and significant increases in neutralizing antibody, as well as cellular immune responses against multiple SARS-CoV-2 variants
GeoVax Announces Multiple Actions By Global Patent Offices Strengthening The Company's Intellectual Property Assets; Intellectual Property Assets Strengthened For Cancer Immunotherapy Program And For Marburg Virus And HIV Vaccines
GOVX
13 Feb 24
"Compositions and Methods for Generating an Immune Response to a Tumor Associated Antigen." The allowed claims are directed to recombinant MVA viral
- Prev
- 1
- Next